The report will be delivered in 2-3 business days.

Antiglaucoma Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : November 2019 | SKU CODE : 7045 | Format :


The antiglaucoma drug market consists of sales of antiglaucoma drugs which are used in the treatment of glaucoma. Glaucoma is a disease in which the optic nerve is damaged resulting into irreversible loss of vision and it is often associated with increased pressure of the fluid in eye. The market comprises of segments such as alpha agonists, beta blockers, prostaglandins, combined medication and other. The market does not include the sale of biologics used for the treatment of glaucoma.

The global antiglaucoma drugs market was valued at about $15.62 billion in 2018 and is expected to grow to $20.57 billion at a CAGR of 7.1% through 2022.

The antiglaucoma drugs market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. The North American Market is the largest market for antiglaucoma drugs and is expected to continue to do so during the forecast period.

Incidence of glaucoma increases with age and due to increase in the geriatric population worldwide, governments are launching initiatives to promote awareness on glaucoma and other eye disorders. For instance, the Vision Health initiative by Centers for Disease Control and Prevention (CDC) in the USA aimed to prevent eye disorders including glaucoma and improve the overall eye health. In Australia, the government funded an eye screening program as part of its Vision 2020 initiative to promote awareness and prevent vision loss among the population suffering from glaucoma and other eye disorders. These government initiatives will stimulate the awareness among the people on glaucoma driving the market for anti-glaucoma drugs.

Anti-glaucoma drugs are facing the risk of patent expiration in the USA and Europe. For instance, travaprost and bimatoprost, which are used in the treatment of glaucoma, will lose its patent in 2021. This will result in the launch of generic form of the drugs that are priced lower than branded drugs thereby reducing the overall market growth.

Companies in the antiglaucoma drugs market are developing combination therapies in the treatment of glaucoma disease due to their ability to lower intraocular pressure in glaucoma patients. Most of the combinations therapies are fixed dose drugs as it offers patient the ease of consumption when compared to non-fixed combinations. In 2017, Alcon launched a combination drug, Simbrinza which is fixed combination of Brinzolamide and Brimonidine, to help patients in reducing the intake of multiple drugs for glaucoma.

To get an antiglaucoma drug approved by the United States Food and Drug Administration (USFDA), drug should have comparable intraocular pressure (IOP) lowering efficacy and benefit-to-hazard ration with respect to the benchmark drug. In 2018, Rhopressa (netarsudil) Ophthalmic Solution by Aerie Pharmaceuticals Inc., was approved by the US FDA considering its ability to lower IOP when compared to benchmarked drugs for glaucoma in the market.

In 2018, Astellas Pharma Inc. acquired Quethera Ltd., a gene therapy company based in the UK. With this acquisition, Astellas has gained authority over Quethera's ophthalmic gene therapy program which focuses on developing novel treatment for ocular diseases such as glaucoma.

Major players in the market are Aerie Pharmaceuticals, Inc., ALLERGAN, Novartis AG, Abbott Healthcare and Johnson & Johnson.

    1. Executive Summary

    2. Antiglaucoma Drugs Market Characteristics

    3. Antiglaucoma Drugs Market Size And Growth

    3.1. Global Antiglaucoma Drugs Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Antiglaucoma Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Antiglaucoma Drugs Market Segmentation

    4.1. Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Alpha Agonist

    Beta Blockers

    Prostaglandin Analogs

    Combined Medication

    Others

    4.2. Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Open-Angle Glaucoma

    Angle-Closure Glaucoma

    Normal-Tension Glaucoma

    Congenital Glaucoma

    Other Types Of Glaucoma

    4.3. Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospital Prescription drugs

    Over-the counter drugs

    5. Antiglaucoma Drugs Market Regional And Country Analysis

    5.1. Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Antiglaucoma Drugs Market  

    6.1. Asia-Pacific Antiglaucoma Drugs Market Overview  

    6.2. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Antiglaucoma Drugs Market  

    7.1. China Antiglaucoma Drugs Market Overview  

    7.2. China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Antiglaucoma Drugs Market  

    8.1. India Antiglaucoma Drugs Market Overview  

    8.2. India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Antiglaucoma Drugs Market  

    9.1. Japan Antiglaucoma Drugs Market Overview  

    9.2. Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Antiglaucoma Drugs Market  

    10.1. Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Antiglaucoma Drugs Market  

    11.1. Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Antiglaucoma Drugs Market  

    12.1. South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Antiglaucoma Drugs Market  

    13.1. Western Europe Antiglaucoma Drugs Market Overview

    13.2. Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Antiglaucoma Drugs Market  

    14.1. UK Antiglaucoma Drugs Market Overview

    14.2. UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Antiglaucoma Drugs Market  

    15.1. Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Antiglaucoma Drugs Market  

    16.4. France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.5. France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Antiglaucoma Drugs Market  

    17.1. Eastern Europe Antiglaucoma Drugs Market Overview

    17.2. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Antiglaucoma Drugs Market  

    18.1. Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Antiglaucoma Drugs Market  

    19.1. North America Antiglaucoma Drugs Market Overview

    19.2. North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Antiglaucoma Drugs Market  

    20.1. USA Antiglaucoma Drugs Market Overview

    20.2. USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Antiglaucoma Drugs Market  

    21.1. South America Antiglaucoma Drugs Market Overview

    21.2. South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Antiglaucoma Drugs Market  

    22.1. Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Antiglaucoma Drugs Market  

    23.1. Middle East Antiglaucoma Drugs Market Overview

    23.2. Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Antiglaucoma Drugs Market  

    24.1. Africa Antiglaucoma Drugs Market Overview

    24.2. Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Antiglaucoma Drugs Market Competitive Landscape And Company Profiles

    25.1. Antiglaucoma Drugs Market Competitive Landscape

    25.2. Antiglaucoma Drugs Market Company Profiles

    25.2.1. Aerie Pharmaceuticals, Inc

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. ALLERGAN

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Novartis AG

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Abbott Healthcare

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Johnson & Johnson

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market

    27. Antiglaucoma Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Antiglaucoma Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: China, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: India, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: India, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: Japan, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: Japan, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: Australia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Australia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Indonesia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: South Korea, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Western Europe, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: UK, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: UK, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: Germany, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: Germany, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: France, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: France, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Russia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Russia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: North America, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: North America, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: USA, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: USA, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: South America, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: South America, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Brazil, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Middle East, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Africa, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Africa, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Aerie Pharmaceuticals, Inc Financial Performance
  • Table 47: ALLERGAN Financial Performance
  • Table 48: Novartis AG Financial Performance
  • Table 49: Abbott Healthcare Financial Performance
  • Table 50: Johnson & Johnson Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: China, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: India, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: India, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: Japan, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Australia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: South Korea, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: UK, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: UK, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: Germany, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: France, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: France, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Russia, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: North America, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: North America, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: USA, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: USA, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: South America, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: South America, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Brazil, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Middle East, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Africa, Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Aerie Pharmaceuticals, Inc Financial Performance
  • Figure 47: ALLERGAN Financial Performance
  • Figure 48: Novartis AG Financial Performance
  • Figure 49: Abbott Healthcare Financial Performance
  • Figure 50: Johnson & Johnson Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)